Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KOSDAQ - Delayed Quote KRW

ABL Bio Inc. (298380.KQ)

68,700.00
+3,800.00
+(5.86%)
At close: 3:30:22 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
33,403,030.15
33,403,030.15
65,547,054.62
67,300,799.41
5,332,068.94
Gross Profit
33,403,030.15
33,403,030.15
65,547,054.62
67,300,799.41
5,332,068.94
Operating Expense
92,712,098.83
92,712,098.83
68,174,891.66
66,394,317.13
56,522,988
Operating Income
-59,309,068.68
-59,309,068.68
-2,627,837.04
906,482.28
-51,190,919.06
Net Non Operating Interest Income Expense
3,084,138.35
3,084,138.35
1,300,146.83
194,780.58
5,312,071.33
Pretax Income
-55,529,347.88
-55,529,347.88
-2,646,663.29
3,208,631
-43,557,942.98
Net Income Common Stockholders
-55,529,347.88
-55,529,347.88
-2,646,663.29
3,208,631
-43,557,942.98
Basic EPS
-1.16k
--
-55.00
67.00
-927.00
Diluted EPS
-1.16k
--
-55.00
67.00
-927.00
Basic Average Shares
48,035.77
--
48,121.15
47,890.02
46,988.07
Diluted Average Shares
48,035.77
--
48,121.15
47,890.02
46,988.07
Total Operating Income as Reported
-59,377,417.08
-59,377,417.08
-2,617,101.13
907,999.45
-52,305,340.53
Total Expenses
92,712,098.83
92,712,098.83
68,174,891.66
66,394,317.13
56,522,988
Net Income from Continuing & Discontinued Operation
-55,529,347.88
-55,529,347.88
-2,646,663.29
3,208,631
-43,557,942.98
Normalized Income
-55,889,596.88
-55,889,596.88
-4,045,023.29
3,931,102.93
-50,215,869.98
Interest Income
1,876,951
1,876,951
1,293,888
233,745
99,717
Interest Expense
36,044
36,044
2,150,649
1,325,978
41,978
Net Interest Income
3,084,138.35
3,084,138.35
1,300,146.83
194,780.58
5,312,071.33
EBIT
-55,493,303.88
-55,493,303.88
-496,014.29
4,534,609
-43,515,964.98
EBITDA
-53,083,365.28
-53,083,365.28
2,093,764.55
6,859,435
-41,357,651.98
Reconciled Depreciation
2,409,938
2,409,938
2,589,778
2,324,826
2,158,313
Net Income from Continuing Operation Net Minority Interest
-55,529,347.88
-55,529,347.88
-2,646,663.29
3,208,631
-43,557,942.98
Total Unusual Items Excluding Goodwill
360,249
360,249
1,398,360
-996,513
6,657,927
Total Unusual Items
360,249
360,249
1,398,360
-996,513
6,657,927
Normalized EBITDA
-53,443,614.28
-53,443,614.28
695,404.55
7,855,948
-48,015,578.98
Tax Rate for Calcs
--
--
--
0
--
Tax Effect of Unusual Items
--
--
--
-274,041.08
--
12/31/2021 - 12/19/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

085660.KQ Chabiotech Co.,Ltd.
11,320.00
+5.01%
 
226950.KQ OliX Pharmaceuticals, Inc
52,000.00
+2.16%
 
096530.KQ Seegene, Inc.
25,350.00
0.00%
 
214450.KQ PharmaResearch Co., Ltd.
358,500.00
-0.97%
 
028300.KQ HLB Co., Ltd.
53,500.00
0.00%
 
068270.KS Celltrion, Inc.
157,600.00
+0.13%
 
196170.KQ ALTEOGEN Inc.
389,000.00
+0.65%
 
DNLI Denali Therapeutics Inc.
13.15
+3.22%
 
VXRT Vaxart, Inc.
0.3181
-7.50%
 
CRSP CRISPR Therapeutics AG
37.82
+0.13%